Sage Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	432	425	396	340	-
Market Cap Growth	3.04%	7.07%	16.59%	-	-
Enterprise Value	469	378	361	271	-
Last Close Price	0.81	0.80	0.75	0.80	-
Forward PE	-	-	9.33	10.67	-
PS Ratio	41.63	38.46	76.63	60.70	-
PB Ratio	2.60	2.53	2.30	3.50	-
P/TBV Ratio	2.60	2.53	2.30	3.50	-
P/OCF Ratio	-	192.71	-	-	-
EV/Sales Ratio	45.25	34.26	69.84	48.39	-
Debt / Equity Ratio	0.23	0.01	0.01	0.01	0.03
Asset Turnover	0.05	0.05	0.03	0.08	-
Quick Ratio	0.09	0.28	3.02	7.52	0.93
Current Ratio	0.10	0.31	3.05	7.63	1.54
Return on Equity (ROE)	-6.69%	-5.22%	-4.88%	-19.73%	-
Return on Assets (ROA)	-3.13%	-2.85%	-3.59%	-11.57%	-
Return on Capital (ROIC)	-3.44%	-3.51%	-4.27%	-14.41%	-
Earnings Yield	-2.62%	-2.10%	-1.66%	-3.28%	-
FCF Yield	-25.26%	-19.38%	-19.89%	-6.95%	-
Buyback Yield / Dilution	-14.04%	-20.67%	-20.71%	-25.52%	-

Updated Nov 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.